ATOMIC Trial ASCO 2025: Key Results RevealedOn June 1, 2025, the ASCO Annual Meeting in Chicago presented the ATOMIC trial ASCO 2025 results. This phase III study focuses on stage III dMMR colon cancer treatment. Researchers tested atezolizumab with mFOLFOX6 against mFOLFOX6 alone. The trial showed a clear improvement in disease-free survival for patients. This … Continue reading ATOMIC Trial Results at ASCO 2025: Breakthrough for dMMR Stage III Colon Cancer